PVALB Human

Parvalbumin Human Recombinant
Shipped with Ice Packs
In Stock

Description

Introduction to PVALB Human

PVALB is a low molecular weight protein (~9–11 kDa) belonging to the EF-hand calcium-binding albumin family . It is expressed in fast-twitch muscles, GABAergic interneurons, and endocrine tissues . Structurally, it contains three EF-hand motifs that enable calcium sequestration, facilitating muscle relaxation and modulating neuronal excitability . Its gene, PVALB, is located on chromosome 22 and produces isoforms implicated in calcium signaling and synaptic regulation .

Key Features:

  • Calcium Binding: Binds two calcium ions via EF-hand domains, aiding rapid calcium buffering .

  • Isoforms: Three evolutionary lineages exist:

    SubtypeExpression ProfileClinical Relevance
    α-ParvalbuminHumans, cartilaginous fishMajor allergen in cartilaginous fish
    β-1 (Oncomodulin)Humans, miceLinked to cochlear function
    β-2 ParvalbuminBony fish (e.g., salmon, carp)Primary allergen in bony fish
  • Tissue Distribution: Highest in fast-twitch muscles, cortical interneurons (basket, chandelier cells), and cerebellar Purkinje neurons .

Role in Neurological Function

PVALB+ interneurons regulate cortical gamma oscillations (30–80 Hz), which are critical for memory and sensory processing . Key findings include:

  • Genetic Association: PVALB-correlated genes explain 21–33% of heritable variance in resting-state brain activity, particularly in prefrontal and somatosensory regions .

  • Circuit Dynamics: Optogenetic stimulation of PVALB+ interneurons enhances gamma synchrony, improving cognitive flexibility in rodent models .

  • Neurodevelopmental Timing: In humans, PVALB expression begins postnatally, peaking in adolescence, contrasting with prenatal expression in non-human primates .

Disorders Linked to PVALB Dysregulation:

ConditionPathological FindingsSource
Schizophrenia↓ PVALB and GAD67 in cortical interneurons; altered gamma oscillations
Alzheimer’s DiseaseEarly mitochondrial dysfunction in PVALB+ interneurons; ↓ Akt/mTOR signaling
EpilepsyLoss of PVALB+ neurons in hippocampus; synaptic reorganization
Autism Spectrum Disorder↑ PVALB+ interneuron density in hippocampal CA1/CA3
Fish Allergyβ-parvalbumin in bony fish is a major allergen (cross-reactivity <20% with α-isoforms)

Mechanistic Insights:

  • Postmortem Studies: Child abuse survivors show a 3-fold increase in unmyelinated PVALB+ interneurons with perineuronal nets (PNNs) in the prefrontal cortex .

  • Proteomics: PVALB+ interneurons in early Alzheimer’s models exhibit ↓ mitochondrial proteins (e.g., COX5B, ATP5F1) and ↑ synaptic scaffolding proteins .

Developmental Aspects

Human PVALB+ interneurons mature postnatally, contrasting with prenatal development in macaques :

  • Hippocampal Development: PVALB expression begins at birth in Ammon’s horn and after 1 month in the dentate gyrus .

  • Maturation Markers: Cell size and density correlate with age (e.g., +0.45 µm/year in dentate gyrus) .

Experimental Models:

  • Stem Cell Differentiation: LHX6 overexpression in pluripotent stem cells yields 21% PVALB+ neurons with fast-spiking properties .

  • Glial Reprogramming: Direct conversion of glial precursors to PVALB+ interneurons in 3D cultures achieves functional maturity within weeks .

  • Transplantation: Grafted human PVALB+ interneurons integrate into mouse brains, restoring inhibitory tone .

Future Directions

Current research focuses on:

  1. Disease Modeling: Using patient-derived PVALB+ interneurons to study schizophrenia and Alzheimer’s .

  2. Allergen Engineering: Modifying β-parvalbumin in fish to reduce allergenicity .

  3. Gene Therapy: Targeting PVALB expression to restore cortical inhibition in epilepsy .

Product Specs

Introduction
Parvalbumin alpha (PVALB), a member of the EF hand protein family, exhibits high affinity for calcium ions and shares structural and functional similarities with calmodulin and troponin C. Its expression is observed in a specific subset of GABAergic interneurons, which are thought to play a crucial role in regulating the balance between excitatory and inhibitory signals within the cortex and hippocampus.
Description
Recombinant human PVALB, produced in E. coli, is a non-glycosylated polypeptide chain with a 24 amino acid His tag at the N-terminus. It comprises 134 amino acids (residues 1-110 of the PVALB sequence) and has a molecular weight of 14.6 kDa. Purification is achieved using proprietary chromatographic methods.
Physical Appearance
Clear, colorless solution, sterile-filtered.
Formulation
The PVALB solution is provided at a concentration of 1 mg/ml in a buffer consisting of 20 mM Tris-HCl (pH 8.0), 1 mM DTT, 10% glycerol, and 50 mM NaCl.
Stability
For short-term storage (2-4 weeks), keep at 4°C. For extended storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Repeated freezing and thawing should be avoided.
Purity
Purity is determined to be greater than 95% by SDS-PAGE analysis.
Synonyms
Parvalbumin alpha, PVALB, D22S749, MGC116759.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSHMSMTDL LNAEDIKKAV GAFSATDSFD HKKFFQMVGLKKKSADDVKK VFHMLDKDKS GFIEEDELGF ILKGFSPDAR DLSAKETKML MAAGDKDGDG KIGVDEFSTL VAES.

Q&A

What are the standard biomarkers and methodologies for identifying PVALB-expressing interneurons in human brain tissue?

PVALB (parvalbumin) interneurons are identified using a combination of molecular, electrophysiological, and morphological criteria. Immunohistochemistry (IHC) with antibodies against parvalbumin remains the gold standard for initial identification, but validation requires co-staining with GABAergic markers (e.g., GAD67) to confirm inhibitory identity . Single-cell RNA sequencing (scRNA-seq) has revealed subtype-specific transcriptional profiles, distinguishing PVALB+ neurons from somatostatin (SST+) or calretinin (CR+) subtypes . Electrophysiologically, mature human PVALB interneurons exhibit fast-spiking (FS) properties with high-frequency action potentials (50–100 Hz) and short afterhyperpolarization durations, which can be recorded via patch-clamp .

Key validation steps:

  • Molecular: Co-expression of PVALB with GABA synthesis enzymes (GAD65/67).

  • Functional: Presence of perisomatic synaptic contacts on pyramidal neurons.

  • Transcriptomic: Enrichment of KCNC1 (Kv3.1 potassium channels) and SLC32A1 (VGAT) in scRNA-seq clusters .

How do researchers optimize differentiation protocols to generate PVALB-positive neurons from human pluripotent stem cells (hPSCs)?

Protocols for generating PVALB interneurons from hPSCs rely on recapitulating developmental cues from the medial ganglionic eminence (MGE). A widely used method involves:

  • Dorsoventral patterning: Inhibition of BMP/Wnt pathways to induce default dorsal fate, followed by SHH activation to ventralize progenitors .

  • Transcriptional programming: Overexpression of LHX6, a master regulator of MGE-derived interneurons, increases PVALB+ yields to ~21% in 80 days .

  • 3D organoid maturation: Glia-guided differentiation in Matrigel-based matrices enhances synaptic integration and FS property acquisition .

Critical variables:

  • Timing of LHX6 induction (optimal at day 17–25 of differentiation) .

  • Co-culture with astrocytes to provide trophic support (BDNF, GDNF) .

What electrophysiological properties distinguish mature human PVALB interneurons from other GABAergic subtypes?

PVALB interneurons exhibit unique electrophysiological signatures:

  • Fast-spiking (FS) phenotype: Sustained high-frequency firing (>50 Hz) without adaptation, mediated by Kv3.1/Kv3.2 potassium channels .

  • Short spike half-width: <0.5 ms due to rapid Na+ channel inactivation .

  • Perisomatic targeting: Unitary inhibitory postsynaptic currents (uIPSCs) with large amplitude (≥100 pA) and rapid decay (τ ≈ 5 ms) .

Validation workflow:

  • Step 1: Confirm FS properties via current-clamp.

  • Step 2: Measure uIPSC kinetics on pyramidal neurons.

  • Step 3: Block Kv3 channels with 4-AP (1 mM) to abolish FS firing .

How can conflicting data on PVALB interneuron susceptibility to oxidative stress be resolved through experimental design?

Discrepancies in oxidative stress studies often arise from differences in in vitro models and stress induction methods. To address this:

  • Standardize stress paradigms: Compare ROS induction via menadione (10 µM) vs. hypoxia (1% O₂) across identical differentiation batches .

  • Incorporate isogenic controls: Use CRISPR-edited hPSC lines with PVALB knockouts to isolate genotype-specific vulnerabilities .

  • Multi-omics validation: Pair RNA-seq (to assess SOD2, GPX4 expression) with metabolomics (glutathione levels) for mechanistic clarity .

Example conflict resolution:
A 2024 study found 3D organoid-derived PVALB neurons resist hypoxia better than 2D cultures, likely due to astrocyte-mediated glutathione secretion . Replicating this in 2D with astrocyte-conditioned media resolved prior contradictions .

What strategies address the inconsistent functional integration of transplanted PVALB interneurons in preclinical models?

Graft-host synaptic mismatches are common due to species-specific cues. Improved methods include:

  • Host preconditioning: Transiently silence endogenous interneurons with Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) to reduce competition .

  • Activity-dependent survival: Co-express optogenetic actuators (ChR2) in grafts and apply 20 Hz light pulses to reinforce synaptic plasticity .

  • Circuit-specific targeting: Inject retrograde AAVs carrying neurotrophic factors (e.g., NT-3) into host pyramidal neuron regions to guide graft projections .

Data from recent trials:

Parameter2D Grafts (n=12)3D Organoid Grafts (n=12)
Synaptic density8.2 ± 1.3/100 µm14.7 ± 2.1/100 µm
FS property retention62%89%

How do researchers reconcile disparities in transcriptomic profiles of PVALB neurons across different cortical regions?

Region-specific PVALB subtypes exhibit distinct KCNH5 (Kv10.2) and SYT2 expression levels. To harmonize findings:

  • Microdissection precision: Laser-capture PVALB+ cells from layer-specific cortical regions (e.g., LII/III vs. LV/VI) .

  • Cross-study alignment: Re-analyze public scRNA-seq datasets (e.g., Allen Brain Atlas) using uniform clustering (resolution=0.8) .

  • Functional clustering: Group neurons by electrophysiological metrics (e.g., input resistance) before transcriptomic analysis .

Case study:
A re-analysis of 15 datasets revealed two PVALB subtypes:

  • Type A: High KCNC1, predominant in prefrontal cortex.

  • Type B: High SYT2, enriched in motor cortex .

Product Science Overview

Structure and Function

Parvalbumin contains two EF-hand domains, which are helix-loop-helix structural motifs capable of binding calcium ions . These domains enable parvalbumin to act as a slow calcium buffer, accelerating the initial phase of calcium decay after an action potential . This function is crucial in regulating short-term synaptic plasticity and muscle relaxation after contraction .

Expression and Localization

Parvalbumin is expressed in specific subclasses of GABAergic interneurons, which are inhibitory neurons that play a key role in maintaining the balance between excitation and inhibition in the cortex and hippocampus . It is also found in the soma and processes of these neurons .

Biological Significance

The role of parvalbumin in the nervous system is significant. It helps in the rapid clearance of calcium ions, which is essential for the proper functioning of neurons and muscle cells . Altered function of parvalbumin-positive interneurons has been implicated in various neurological disorders, including Alzheimer’s disease, autism spectrum disorder, schizophrenia, and bipolar disorder .

Recombinant Parvalbumin

Recombinant human parvalbumin is produced using expression systems such as E. coli . This recombinant form retains the structural and functional properties of the native protein, making it useful for research purposes. It is often tagged with a His-tag to facilitate purification and detection .

Applications

Recombinant parvalbumin is widely used in research to study calcium signaling, synaptic plasticity, and muscle physiology. It is also used in the development of antibodies and in various biochemical assays .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.